Search results
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 1 day agoInvestors have put their hopes in Moderna's (MRNA 2.64%) next potential product, a respiratory syncytial virus (RSV) vaccine. The RSV vaccine promises to...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 2 days agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 2 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
Cramer's Lightning Round: 'I'm a believer' in Moderna
CNBC· 20 hours ago"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to...
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...